Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2000
11/22/2000CN1274353A Halogen substituted tetracyclic tetrahydrofuran derivatives
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1058723C D4T polymorphic form I process
11/22/2000CN1058712C Microbicidal triazolyl derivatives
11/22/2000CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same
11/22/2000CN1058709C Amide compounds for medical treatment
11/21/2000US6150557 Compounds
11/21/2000US6150527 Synthetic multimerizing agents
11/21/2000US6150526 Piperidine derivative having renin inhibiting activity
11/21/2000US6150416 2-hydroxy-3-(substitued benzyl)-n,n'-bis(substituted carbonyl)-n-(substituted)-1,3-propanediamine based compounds; use in the detection, labelling and inhibition of cathepsin d
11/21/2000US6150397 5-aroylnaphthalene derivatives as anti-inflammatory agents
11/21/2000US6150394 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
11/21/2000US6150379 Compounds and compositions as anticoagulants
11/21/2000US6150375 Inhibitors of both of the human 5ar isozymes; benign prostate hyperplasia, male pattern baldness, acne vulgaris, seborrhea, androgenic alopecia, hirsutism and prostate cancer; blocks the conversion of testosterone to 5-alpha-dihydrotestosterone
11/21/2000US6150362 Administering 1,3,5-substituted triazine compounds to the patient suffering from angiogenic diseases
11/21/2000US6150356 Potassium channel inhibitors and method
11/21/2000US6150355 Phenylpiperidine derivative
11/21/2000US6150352 Antagonists of gonadotropin releasing hormone
11/16/2000WO2000068225A1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068208A1 Pyrimidinones derivatives for the treatment of atherosclerosis
11/16/2000WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof
11/16/2000WO2000068203A1 Cyclic compounds and uses thereof
11/16/2000WO2000068202A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
11/16/2000WO2000068201A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000WO2000068198A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000WO2000068197A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ[e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067801A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067735A2 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/16/2000WO2000067729A1 Regimen and kit for amelioration of premature ejaculation
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000020358A3 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
11/16/2000WO2000015634A3 Hiv protease inhibitors
11/16/2000DE19923001A1 New epothilone derivatives, used as mitosis regulators e.g. for treating malignant tumors, psoriasis or arthritis
11/16/2000DE19922317A1 Preparation of N-(Benzofuranyl-alkoxycarbonyl)-tryptophan ester derivative, used as tachykinin antagonist intermediate, comprises reacting tryptophan ester with carbon dioxide and carbonate, then with benzofuran derivative
11/16/2000DE19922316A1 N-(Benzofuranyl-alkoxycarbonyl)-tryptophan ester preparation, for use as tachykinin receptor antagonist intermediate, by reacting hydroxyalkyl-benzofuran with disuccinimidyl carbonate, then with tryptophan ester
11/16/2000DE19922315A1 N-(Benzofuranyl-alkoxycarbonyl)-tryptophan ester preparation, for use as tachykinin receptor antagonist intermediate, by reacting tryptophan ester with N,N'-carbonyl diimidazole then benzofuran derivative
11/16/2000CA2373073A1 Cyclic compounds and uses thereof
11/16/2000CA2373035A1 3a,4,5,9b-tetrahydro-1h-benz¬e|indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders
11/16/2000CA2372663A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000CA2371472A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
11/16/2000CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000CA2366201A1 Use of selective antagonists of the .alpha.1b-adrenergic receptor for improvement of sexual dysfunction
11/15/2000EP1052261A1 Pyran derivatives and use thereof
11/15/2000EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics.
11/15/2000EP1052254A1 Nitrogenous heterocyclic derivatives and medicine thereof
11/15/2000EP1051413A1 Quinoline derivatives as antibacterials
11/15/2000EP1051407A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
11/15/2000EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/15/2000EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/15/2000CN1273584A Imidazolyl-cyclic acetals
11/15/2000CN1058495C Polycyclic systems compound and derivatives thereof as neurotransmitter release enhancers useful in the treatment of cognitive disordes and medicine containing them and its use
11/15/2000CN1058490C Tetrazolinone derivatives
11/14/2000US6147232 Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147111 Kidney, brain, and cardiovascular disorders; vasodilation
11/14/2000US6147110 Heterocyclic compounds
11/14/2000US6147105 Use in the treatment of estrogen-related diseases
11/14/2000US6147083 Novel substituted 1,2-ethanediamine derivatives which antagonize the pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins, useful for the treatment of asthma, etc.
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147077 2R,4S-hydroxyitraconazole isomers
11/14/2000CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
11/09/2000WO2000066589A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
11/09/2000WO2000066580A2 Antifungal ethers
11/09/2000WO2000066568A1 Pesticidal triazine derivatives
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066562A1 Pyrazoles having antiinflammatory activity
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066170A1 Prucalopride oral solution
11/09/2000WO2000066120A1 Novel catechols as antimicrobial agents
11/09/2000WO2000066119A1 Novel prolines as antimicrobial agents
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066100A2 2r,4s-hydroxyitraconazole isomers
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000035906A3 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000DE19920551A1 Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen Substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
11/09/2000DE10021568A1 New pyrimidinyl aryl sulfoxide or sulfone derivatives useful as herbicides and plant growth inhibitors
11/09/2000CA2372595A1 Contraceptive compositions containing indoline derivatives and progestational agents
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371629A1 3,3-substituted indoline derivatives
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2369357A1 2r,4s-hydroxyitraconazole isomers
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049691A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
11/08/2000EP1049680A1 Substituted aminoalkylidenamino triazines as herbicides
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049674A1 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine
11/08/2000EP1049673A1 Heterocyclic amidines as callicrein protease inhibitors